C. Nielsen

发表

Malaria Vaccines: Recent Advances and New Horizons

J. Rayner, B. Sack, C. King, 2018, Cell host & microbe.

The Application of Single-Cell RNA Sequencing in Vaccinology

E. Barnes, Andrew J. C. Russell, C. Nielsen, 2020, Journal of immunology research.

Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes.

S. Buus, A. Fomsgaard, C. Nielsen, 1999, Vaccine.

Calorie Restriction Attenuates Terminal Differentiation of Immune Cells

C. Bottomley, E. Riley, C. Beaver, 2017, Front. Immunol..

Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

D. Lauffenburger, D. Douek, G. Alter, 2022, medRxiv.

Poor CD4+ T Cell Immunogenicity Limits Humoral Immunity to P. falciparum Transmission-Blocking Candidate Pfs25 in Humans

A. Hill, C. Nielsen, C. Long, 2021, Frontiers in Immunology.

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Juliana K. Wambua, J. McCarthy, J. Vekemans, 2017, JCI insight.

Synergy between Common γ Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation

E. Riley, C. Nielsen, M. Goodier, 2016, Front. Immunol..

C. Bottomley, S. Moore, E. Riley, 2020, Frontiers in Immunology.

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype

M. Lievens, J. Vekemans, C. Ockenhouse, 2018, Vaccine.

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics

A. Lawrie, W. Nahrendorf, S. Draper, 2022, Frontiers in Immunology.

Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection

E. Riley, C. Nielsen, R. Behrens, 2016, The Journal of Immunology.

Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.

C. Bottomley, S. Moore, E. Riley, 2014, Blood.

IL-15 Promotes Polyfunctional NK Cell Responses to Influenza by Boosting IL-12 Production

E. Riley, C. Nielsen, M. Goodier, 2018, The Journal of Immunology.

Human lymphoid tissue sampling for vaccinology

C. Nielsen, Catherine Mkindi, Karolina M. Kwiatkowska, 2022, Frontiers in Immunology.

Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.

D. Hougaard, L. Vinner, C. Nielsen, 2000, AIDS research and human retroviruses.

The impact of cytomegalovirus infection on natural killer cell responses to vaccines

C. Nielsen, 2016 .

Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors

B. Haynes, P. Borrow, Yue Chen, 2021, Cell reports. Medicine.

Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools

Guilhem Richard, Leonard Moise, William D. Martin, 2020, Frontiers in Immunology.

Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals

C. Bottomley, E. Riley, C. Nielsen, 2015, The Journal of Immunology.

Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens

E. Riley, R. McGregor, C. Nielsen, 2014, Immunology.

Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease

E. Riley, C. Nielsen, M. Goodier, 2013, Front. Immunol..

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly

J. Rayner, T. Otto, A. Blagborough, 2021, JCI insight.

Controlled human malaria infection with PvW1: a new clone of Plasmodium vivax with high quality genome assembly

J. Rayner, T. Otto, A. Blagborough, 2021, medRxiv.

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

G. Alter, M. White, S. Faust, 2021, Med.

Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization

A. D. De Groot, V. Kotraiah, S. Draper, 2021, Frontiers in Immunology.

Cytomegalovirus-Infected Individuals H1N1 Influenza Vaccine Antigens in Human Impaired NK Cell Responses to Pertussis and

C. Bottomley, E. Riley, C. Nielsen, 2015 .

A Replicating Adenovirus Capsid Display Recombinant Elicits Antibodies against Plasmodium falciparum Sporozoites in Aotus nancymaae Monkeys

Kasey A. Karen, C. Nielsen, F. Zavala, 2014, Infection and Immunity.

Impaired Natural Killer Cell Responses to Pertussis and H 1 N 1 Influenza Vaccine 1 Antigens in Human Cytomegalovirus-Infected Individuals 1 2 3

C. Bottomley, E. Riley, C. Nielsen, 2018 .

Analyses of vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens

A. Olotu, C. Chitnis, S. Draper, 2023, medRxiv.

Impact of a blood-stage vaccine on Plasmodium vivax malaria

R. Moon, C. Huon, C. Chitnis, 2022, medRxiv.

Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

A. Olotu, A. Lawrie, S. Draper, 2023, medRxiv.

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

R. Moon, C. Huon, C. Chitnis, 2023, Science Translational Medicine.

PvDBPII-Matrix M elicits polyfunctional antibodies that limit parasite growth in a challenge trial

F. Agou, C. Huon, C. Chitnis, 2023, medRxiv.

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults.

A. Olotu, Saumu Ahmed, A. Ali, 2023, Med.

Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine

D. Lauffenburger, D. Douek, G. Alter, 2023, JCI insight.

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial

C. Huon, S. Draper, C. Nielsen, 2024, NPJ vaccines.